XML 22 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury stock
Retained Earnings
Beginning Balance at Mar. 31, 2015 $ 435,750 $ 51 $ 298,101 $ (4,645) $ (169,516) $ 311,759
Beginning Balance (in shares) at Mar. 31, 2015   50,812,548     10,004,743  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (28,369)         (28,369)
Unrealized net investment gains (losses) 3     3    
Unrealized net gains (losses) on derivative financial instruments 1,063     1,063    
Cumulative translation adjustments 1,446     1,446    
Recognition from actuarial net gain from pension and other post-retirement plan 632     632    
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   736,170        
Stock-based compensation expense for restricted stock units granted to employees 26,609   26,609      
Issuance of common stock under employee stock purchase plan 10,560   10,560      
Issuance of common stock under employee stock purchase plan (in shares)   447,252        
Repurchase of treasury stock (311,850)       $ (311,850)  
Repurchase of treasury stock (in shares)         10,402,402  
Issuance of shares related to the Comms Transaction 2,305,611 $ 62 2,305,549      
Issuance of shares related to the Comms Transaction (in shares)   62,499,644        
Tax effect from share-based compensation awards 1,926   1,926      
Ending Balance at Mar. 31, 2016 2,443,382 $ 114 2,642,745 (1,501) $ (481,366) 283,390
Ending Balance (in shares) at Mar. 31, 2016   114,495,614     20,407,145  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 33,291         33,291
Unrealized net investment gains (losses) (59)     (59)    
Unrealized net gains (losses) on derivative financial instruments (54)     (54)    
Cumulative translation adjustments (1,000)     (1,000)    
Recognition from actuarial net gain from pension and other post-retirement plan (858)     (858)    
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   950,159        
Stock-based compensation expense for restricted stock units granted to employees 36,449   36,449      
Issuance of common stock under employee stock purchase plan 15,697   15,697      
Issuance of common stock under employee stock purchase plan (in shares)   471,658        
Repurchase of treasury stock (89,555)       $ (89,555)  
Repurchase of treasury stock (in shares)         3,468,998  
Tax effect from share-based compensation awards (1,045)   (1,045)      
Ending Balance at Mar. 31, 2017 2,436,250 $ 116 2,693,846 (3,472) $ (570,921) 316,681
Ending Balance (in shares) at Mar. 31, 2017   115,917,431     23,876,143  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 79,812         79,812
Unrealized net investment gains (losses) (6)     (6)    
Unrealized net gains (losses) on derivative financial instruments 131     131    
Cumulative translation adjustments 4,889     4,889    
Recognition from actuarial net gain from pension and other post-retirement plan 1,353     1,353    
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,216,535        
Stock-based compensation expense for restricted stock units granted to employees 43,425   43,425      
Issuance of common stock under employee stock purchase plan 17,849   17,849      
Issuance of common stock under employee stock purchase plan (in shares)   610,947        
Repurchase of treasury stock (514,922)   (90,000)   $ (424,922)  
Repurchase of treasury stock (in shares)         13,598,747  
Ending Balance at Mar. 31, 2018 $ 2,068,782 $ 117 $ 2,665,120 $ 2,895 $ (995,843) $ 396,493
Ending Balance (in shares) at Mar. 31, 2018   117,744,913     37,474,890